Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement for Left-Sided Obstructive Colonic Cancer

NCT05202314 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Neoadjuvant Chemotherapy
Stent
Obstruction
Immunotherapy

Interventions

DRUG: Immunotherapy (Camrelizumab)

Sponsor

Beijing Chao Yang Hospital